The diagnosis and treatment of peripheral neuropathy from any cause has come to the forefront of the research community in the past few years. Both past and new diagnostic and treatment options have been and are being studied to better understand and properly treat this debilitating and sometimes devastating disease. One such advancement is the clinical use of quantitative sensory testing. To identify etiology of the neuropathy early, the testing instrument would need to identify changes throughout the course of the disease, have a normative database, and show a clear distinction between the absence or presence of disease. The pressure specified sensory device (PSSD) was developed in 1992 to painlessly investigate the cutaneous pressure thresholds quantitatively and accurately.